Durvalumab, Cetuximab and Radiotherapy in Head Neck Cancer

Clinical trial NCT03051906 · UNKNOWN

Trial details

NCT number: NCT03051906
Sponsor: Azienda Ospedaliero-Universitaria Careggi
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Head and Neck Neoplasms

Start date: 2018-01-01
Primary completion: 2022-01-01
Enrollment: 69

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.